阿奇霉素不同序贯治疗方法对小儿肺炎支原体肺炎的临床效果

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (597 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of different sequential treatments of Azithromycin on Mycoplasma pneumoniae pneumonia (MPP) in children. Methods A total of 68 children with MPP admitted to Maternity & Child Care Center of Xinyu from September 2020 to September 2022 were selected as the research objects, and they were divided into control group (34 cases) and observation group (34 cases) according to random number table method. Children in both groups were treated with Azithromycin. The control group received intravenous injection of Azithromycin for 3 days, withdrawal for 4 days, and then oral Azithromycin dry suspension for 7 days. Observation group was given intravenous Azithromycin for injection for 5 days, drug withdrawal for 4 days, and then oral Azithromycin dry suspension for 5 days. Both groups were treated for 14 days. The clinical efficacy, duration of clinical symptoms, length of hospital stay, immune function, lung function and adverse reactions were compared between the two groups. Results The total clinical effective rate of the observation group was higher than that of the control group, the difference was statistically significant (P＜0.05). There was no significant difference in the time of fever reduction between the two groups (P＞0.05). The disappearance time of lung rales, cough and hospital stay in observation group were shorter than those in control group, and the differences were statistically significant (P＜0.05). There were no significant differences in immunoglobulin E (IgE), interleukin-3 (IL-3) and eosinophils (EOS) between the two groups before treatment (P＞0.05). The IgE, IL-3 and EOS of the two groups after treatment were lower than those before treatment, and the IgE, IL-3 and EOS of the observation group were lower than those of the control group, with statistical significances (P＜0.05). There were no significant differences in forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and FEV1/FVC in the first second before treatment between the two groups (P＞0.05). After treatment, FEV1, FVC and FEV1/FVC in the two groups were higher than those before treatment, and FEV1, FVC and FEV1/FVC in the observation group were higher than those in the control group, with statistical significances (P＜0.05). No obvious adverse reactions were observed in the two groups. Conclusion Using Azithromycin for 5 consecutive days under sequential therapy can effectively improve the clinical symptoms and immune function of MPP children, shorten the hospital stay of children, and is safe, worthy of promotion.

Key words： Mycoplasma pneumoniae pneumonia Sequential therapy Azithromycin Immunity Lung function Adverse reaction

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIANG Haihong LIU Pan LIU Lu ZHANG Min AO Xiaodong GUO Zhonghua

Cite this article:

JIANG Haihong LIU Pan LIU Lu ZHANG Min AO Xiaodong GUO Zhonghua. Clinical effect of different sequential Azithromycin treatments on Mycoplasma pneumoniae pneumonia in children[J]. 中国当代医药, 2024, 31(1): 55-58,63.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2024/V31/I1/55

[1]	童仁香，陈倩，常甄填，等.阿奇霉素序贯治疗联合硫酸特布他林对肺炎支原体肺炎患儿肺功能和血清IL-6、CRP、PCT水平的影响[J].现代生物医学进展，2021，21（16）：3160-3163.
[2]	党利琴，范静.阿奇霉素序贯联合孟鲁司特钠治疗肺炎支原体肺炎患儿临床效果及对免疫指标、血清炎症因子及肺功能的影响研究[J].贵州医药，2021，45（7）：1119-1120.
[3]	王秀丽.阿奇霉素序贯治疗联合特布他林雾化吸入治疗小儿支原体肺炎的临床疗效[J].徐州医科大学学报，2020，40（11）：839-842.
[4]	崔新焕，赵建祎，马利，等.阿奇霉素联合特布他林序贯疗法对儿童肺炎支原体肺炎的疗效观察[J].宁夏医科大学学报，2020，42（1）：71-75.
[5]	王勇，王臻颉.喜炎平联合阿奇霉素序贯治疗小儿支原体肺炎的疗效及对微炎症状态和免疫指标的影响[J].中南医学科学杂志，2022，50（5）：740-743.
[6]	中华医学会儿科学分会呼吸学组，《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识（2015年版）[J].中华实用儿科临床杂志，2015，30（17）：1304-1308.
[7]	于德娇，杨柳，徐丽丽，等.蓝芩口服液联合阿奇霉素治疗小儿肺炎支原体肺炎毒热闭肺证临床研究[J].国际中医中药杂志，2020，42（10）：964-967.
[8]	杨明珠，韩改琳，倪莉.布地奈德联合阿奇霉素序贯疗法对肺炎支原体肺炎患儿血清TNF-α、CRP、IL-5及VEGF的影响研究[J].陕西医学杂志，2019，48（3）：383-385.
[9]	张桂欣.甲泼尼龙联合阿奇霉素序贯疗法治疗儿童难治性肺炎支原体肺炎疗效观察[J].新乡医学院学报，2020， 37（10）：964-967.
[10]	高世悦，朱保卫.红霉素和阿奇霉素序贯治疗小儿肺炎支原体肺炎的临床疗效和不良反应观察[J].贵州医药，2022，46（9）：1393-1394.
[11]	康丽，唐云丽，雷超兰.转移因子口服液联合阿奇霉素序贯疗法治疗肺炎支原体肺炎患儿及对肺泡灌洗液MPO、GM-CSF的影响[J].临床和实验医学杂志，2021，20（11）：1174-1178.
[12]	吕晓娟，汤卫红，沈道江，等.布地奈德联合阿奇霉素序贯疗法对儿童肺炎支原体肺炎肺功能及炎症因子的影响[J].中华全科医学，2019，17（4）：594-596，677.
[13]	刘启洁，何善辉，唐建军，等.急支糖浆联合阿奇霉素治疗小儿支原体肺炎的疗效及对炎症因子水平的影响[J].药物评价研究，2019，42（6）：1164-1167.
[14]	王志坤，王建忠，李彤，等.特布他林联合阿奇霉素序贯治疗儿童肺炎支原体肺炎的临床研究[J].河北医科大学学报，2019，40（7）：820-824.
[15]	章玲玲，刘晓东，江玮.肾上腺皮质激素联合阿奇霉素序贯疗法治疗支原体肺炎患儿的效果及对免疫功能的影响[J].解放军预防医学杂志，2019，37（6）：130-131.
[16]	孙金平，严进霞，瞿剑峰.布地奈德、特布他林雾化吸入联合阿奇霉素序贯疗法治疗小儿支原体肺炎的临床疗效及其对血清炎性因子、可溶性B7-H3、粒细胞集落刺激因子水平的影响[J].实用心脑肺血管病杂志，2019，27（9）：81-85.
[17]	杜东阳，王娜，肖鹏云.通腑泻肺化痰法联合阿奇霉素序贯治疗肺炎支原体感染的临床效果观察[J].世界中医药，2020，15（5）：773-776.
[18]	邓路丹，李彦，赵成顺，等.阿奇霉素序贯治疗联合五虎汤治疗小儿支原体肺炎的临床疗效观察[J].世界中西医结合杂志，2021，16（1）：7-11.
[19]	王亚利，田娟，郭斌.阿奇霉素序贯联合痰热清治疗小儿肺炎支原体肺炎临床观察[J].解放军医药杂志，2019，31（1）：54-58.
[20]	李真.阿奇霉素序贯疗法对儿童肺炎支原体肺炎的疗效及对相关炎症因子的影响[J].儿科药学杂志，2019，25（2）：29-31.